Patents by Inventor Mark Anthony RUTZ

Mark Anthony RUTZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING EPO
    Publication number: 20210355206
    Abstract: The present invention relates to compositions and methods for the inhibition of EPO. The invention provides antibodies and antigen binding fragments thereof that bind to EPO and are able to inhibit EPO-dependent cell proliferation and/or EPO-dependent cell signaling.
    Type: Application
    Filed: July 22, 2021
    Publication date: November 18, 2021
    Inventors: Joy Gispati GHOSH, Michael ROGUSKA, Mark Anthony RUTZ, Igor SPLAWSKI, Kathrin Ulrike TISSOT-DAGUETTE
  • COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING EPO
    Publication number: 20200048341
    Abstract: The present invention relates to compositions and methods for the inhibition of EPO. The invention provides antibodies and antigen binding fragments thereof that bind to EPO and are able to inhibit EPO-dependent cell proliferation and/or EPO-dependent cell signaling.
    Type: Application
    Filed: July 3, 2019
    Publication date: February 13, 2020
    Inventors: Joy GHOSH, Michael ROGUSKA, Mark Anthony RUTZ, Igor SPLAWSKI, Kathrin Ulrike TISSOT-DAGUETTE
  • Compositions and methods for antibodies targeting EPO
    Patent number: 10385127
    Abstract: The present invention relates to compositions and methods for the inhibition of EPO. The invention provides antibodies and antigen binding fragments thereof that bind to EPO and are able to inhibit EPO-dependent cell proliferation and/or EPO-dependent cell signaling.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: August 20, 2019
    Assignee: NOVARTIS AG
    Inventors: Joy Ghosh, Mark Anthony Rutz, Kathrin Ulrike Tissot-Daguette, Igor Splawski, Michael Roguska
  • COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING EPO
    Publication number: 20190135913
    Abstract: The present invention relates to compositions and methods for the inhibition of EPO. The invention provides antibodies and antigen binding fragments thereof that bind to EPO and are able to inhibit EPO-dependent cell proliferation and/or EPO-dependent cell signaling.
    Type: Application
    Filed: September 13, 2018
    Publication date: May 9, 2019
    Applicant: NOVARTIS AG
    Inventors: Joy GHOSH, Mark Anthony RUTZ, Kathrin Ulrike TISSOT-DAGUETTE, Igor SPLAWSKI, Michael ROGUSKA
  • Compositions and methods for antibodies targeting Epo
    Patent number: 10106605
    Abstract: The present invention relates to compositions and methods for the inhibition of EPO. The invention provides antibodies and antigen binding fragments thereof that bind to EPO and are able to inhibit EPO-dependent cell proliferation and/or EPO-dependent cell signaling.
    Type: Grant
    Filed: June 13, 2016
    Date of Patent: October 23, 2018
    Assignee: NOVARTIS AG
    Inventors: Joy Ghosh, Mark Anthony Rutz, Kathrin Ulrike Tissot-Daguette, Igor Splawski, Michael Roguska
  • COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING EPO
    Publication number: 20160280783
    Abstract: The present invention relates to compositions and methods for the inhibition of EPO. The invention provides antibodies and antigen binding fragments thereof that bind to EPO and are able to inhibit EPO-dependent cell proliferation and/or EPO-dependent cell signaling.
    Type: Application
    Filed: June 13, 2016
    Publication date: September 29, 2016
    Applicant: Novartis AG
    Inventors: Joy GHOSH, Mark Anthony RUTZ, Kathrin Ulrike TISSOT-DAGUETTE, Igor SPLAWSKI, Michael ROGUSKA
  • Compositions and methods for antibodies targeting EPO
    Patent number: 9365646
    Abstract: The present invention relates to compositions and methods for the inhibition of EPO. The invention provides antibodies and antigen binding fragments thereof that bind to EPO and are able to inhibit EPO-dependent cell proliferation and/or EPO-dependent cell signaling.
    Type: Grant
    Filed: December 3, 2013
    Date of Patent: June 14, 2016
    Assignee: NOVARTIS AG
    Inventors: Joy Ghosh, Mark Anthony Rutz, Kathrin Ulrike Tissot-Daguette, Igor Splawski, Michael Roguska
  • COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING EPO
    Publication number: 20140199306
    Abstract: The present invention relates to compositions and methods for the inhibition of EPO. The invention provides antibodies and antigen binding fragments thereof that bind to EPO and are able to inhibit EPO-dependent cell proliferation and/or EPO-dependent cell signaling.
    Type: Application
    Filed: December 3, 2013
    Publication date: July 17, 2014
    Applicant: NOVARTIS AG
    Inventors: Joy GHOSH, Mark Anthony RUTZ, Katrin Ulrike TISSOT-DAGUETTE, Igor SPLAWSKI, Michael ROGUSKA